Shanghai Longwood Biopharmaceuticals Co., Ltd.

This study tested a new tablet called LW402 in 72 adults with moderate to severe rheumatoid arthritis who were already taking methotrexate. The goal was to see if adding LW402 for 12 weeks could better control disease activity and improve symptoms like joint pain and swelling. Th…

This study tested an experimental drug called LW402 in 144 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug reduces eczema severity, measured by a 50% improvement in skin symptoms after 12 weeks. Participants were randomly assigned to rec…

This early-stage study tested the safety and tolerability of an experimental drug called LW402 in 36 healthy volunteers. Participants took multiple doses of the drug or a placebo, and researchers monitored for side effects and how the drug moves through the body. The goal was not…